Table 4. Urinary sugar excretions (μmol) and ratios of the control group (n = 10) at baseline and after two weeks intervention, without and with indomethacin challenge.

Values are presented as median and IQR (25-75^th interquartile range). Urinary sugar excretions and ratios at baseline vs. end were compared with the use of a Wilcoxon signed-rank test. L/R, lactulose/rhamnose; S/E, sucralose/erythritol.

Urinary sugar excretion	Without indomethacin			With indomethacin
	Baseline	End	P-value	Baseline	End	P-value
0–5 h sucrose	6.84 [5.65–9.12]	8.69[6.76–10.94]	0.169	9.67 [8.50–18.94]	9.82[6.89–18.70]	0.646
0–5 h lactulose	6.19[5.14–7.24]	9.56 [6.59–13.29]	0.139	11.73[9.30–16.27]	18.06 [10.77–25.39]	0.203
0–5 h rhamnose	287 [216–336]	341 [269–474]	0.285	252 [163–327]	312 [260–464]	0.037
0–5 h L/R ratio	0.023[0.020–0.026]	0.025 [0.021–0.041]	0.093	0.061[0.042–0.074]	0.055 [0.041–0.071]	0.799
5–24 h sucralose	39.48 [31.54–93.49]	44.43[31.41–58.27]	0.333	47.00[37.89–63.15]	53.51[41.63–63.76]	0.386
5–24 h erythritol	3291 [2490–3523]	2565 [2035–2865]	0.059	2731[2164–3073]	3052 [2386–3395]	0.285
5–24 h S/E ratio	0.016 [0.011–0.023]	0.021 [0.013–0.023]	0.203	0.021 [0.012–0.024]	0.018[0.014–0.024]	0.959